knowledge -WSS

knowledge

author：knowledge 2025-09-06 04:30:31 - browse：67

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： How to keep neuroscience’s past racism from being its future

WSS

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Pharma showers House GOP doctor with campaign cash

Hospitals owned by private equity see complications spike 25%

Chris Christie meets with Zelenskyy during Ukraine trip

Can sheer will power keep patients alive in their dying hours?

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

New air purifier tech could be key to improving indoor air quality

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Dobbs anniversary: the lost opportunity of abortion as health care

How I helped Pfizer think through the ethics of Viagra

Walensky prepares to leave CDC — and Congress — behind

How I helped Pfizer think through the ethics of Viagra

New air purifier tech could be key to improving indoor air quality

Hospitals owned by private equity see complications spike 25%

Medical leaders decry Supreme Court decision on affirmative action

Can sheer will power keep patients alive in their dying hours?

leisure time

Readout Newsletter: The latest on Moderna, Apellis, and Merck

The a glaring gap in research on serious mental illness and primary care

In Spain, a hospital brews its own CAR

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Medicare slashes safety net hospital payments by nearly $1 billion

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

hotspot

Wikipedia

knowledge

focus